Search
for
Sort by
Research 61–90 of 1000+
- An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of 5-alpha-dihydrotestosterone in human serum and plasma
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Evaluation of 5α-reductase inhibitory activity of certain herbs useful as antiandrogens
- Health Promotion Potential of Vegetables Cultivated in Northern Thailand: A Preliminary Screening of Tannin and Flavonoid Contents, 5α-Reductase Inhibition, Astringent Activity, and Antioxidant Activities
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Effects of PNU157706, a Dual 5α-Reductase Inhibitor, on Rat Epididymal Sperm Maturation and Fertility1
- A Role for Steroid 5 alpha-reductase 1 in Vascular Remodelling During Endometrial Decidualisation
- Novel inhibitors of 5α-reductase
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Hormonal control of 5.ALPHA.-reductase activity in hamster sebaceous glands.
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Effect of 5α-Dihydrotestosterone and Testosterone on Apoptosis in Human Dermal Papilla Cells
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Clinical use of 5α-reductase inhibitors
- Biochemical Roles of Testosterone and Epitestosterone to 5α-Reductase as Indicators of Male-Pattern Baldness
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Urinary steroids in women with androgenic alopecia
- New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- Side gland of Suncus murinus as a new model of sebaceous gland: 5?-reductase, androgen receptor, and nuclear androgen content in male and female animals
- Idiopathic Hirsutism*
- Alterations in androgen conjugate levels in women and men with alopecia
- An improved synthesis of finasteride from 4-androsten-3,17-dione